Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.
Scientific Congress Publications
Supported by Bayer Pharmaceuticals
WSC 2025
Factor XIa (FXIa) inhibition with asundexian after acute non-cardioembolic stroke or high risk transient ischaemic attack (TIA): methods and baseline data for the OCEANIC-STROKE trial
Date/Time:
Thursday, October 23, 2025 / 10:53 – 11:03 AM, CEST
Presenting Author:
Mukul Sharma
Presentation Session:
Plenary, Awards & Late Breaking 02
Risk factors for ischaemic stroke recurrence in patients with a non-cardioembolic ischaemic stroke in Denmark: observations from ASTRIS
Date/Time:
Thursday, October 23, 2025 / 10:53 – 11:03 AM, CEST
Presenting Author:
David Gaist
Poster Session:
E-Poster Highlights: Disparities, Epidemiology, Nursing, Healthservices, Outcomes
Inclusion of lived experience of stroke across the stroke health ecosystem: meaningful engagement with people affected by diverse health conditions in treatment and care innovation
Date/Time:
Wednesday, October 22, 2025 / 11:45 –11:49 AM, CEST
Presenting Author:
Stacie Broek
Poster Session:
E-Poster Highlights: Disparities, Epidemiology, Nursing, Healthservices, Outcomes
ALTEA observational study: analysis of a large nationally representative US database on the burden of disease among patients with ischaemic stroke and transient ischaemic attack
Date/Time:
Thursday, October 23, 2025 / 12:00 –12:04 PM, CEST
Presenting Author:
Scott Kasner
Poster Session:
E-Poster Highlights: Basic Science & Biomarkers
© 2025 Bayer. All rights reserved.
Bayer and the Bayer Cross are registered trademarks of Bayer.
Copies of the Bayer Pharmaceuticals supported presentations obtained from this platform are for personal use only and may not be reproduced or distributed without permission from the authors.
Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities, and the presentations are shared in the interest of scientific exchange.
For any questions, please contact Medical Information at https://www.medicalinformation.bayer.com/
PP-GEN-ALL-0014-1
